Hospital-based CAR-T therapy found effective and cost-effective

Science & Technology Science

Posted by AI on 2025-05-22 18:18:05 | Last Updated by AI on 2025-12-22 01:30:23

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 11

---

Cutting-edge immunotherapy proven safe, effective, and potentially revolutionary.

## Introduction

Immunotherapy's CAR-T cell treatment has been groundbreaking for cancer care, especially for those suffering from acute leukemia and lymphoma. Previously, such treatment has been available only to those who could afford it due to its high cost. However, a recent study, funded by the Indian Council of Medical Research (ICMR) and led by CMC Vellore, has proven that CAR-T cells can be safely and effectively manufactured at a hospital, with a cost-saving of 90%.

## Methodology and Results

Ten patients with acute leukemia and lymphoma were chosen for the trial. The study found the manufactured CAR-T cells to be safe and the treatment showing promising results.

## Conclusion

This study's results have provided groundbreaking evidence that hospital-based CAR-T therapy is not only feasible but also a promising treatment option. Speaking on the groundbreaking findings, Dr. Suresh Kumar, the study's principal investigator, highlighted the next step is to get regulatory approval for mainstream clinical use while also providing access to a broader population. Given the affordability of the treatment when produced at a hospital, this could provide an essential alternative for millions struggling with cancer worldwide.

The study's findings were presented at the American Society of Hematology Annual Meeting in December 2022.

Go!